Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer

por Schaaf, Zachary A., Ning, Shu, Leslie, Amy R., Sharifi, Masuda, Han, Xianrui, Armstrong, Cameron, Lou, Wei, Lombard, Alan P., Liu, Chengfei, Gao, Allen C.
Publicado 2023

Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer()

por Lombard, Alan P, Liu, Chengfei, Armstrong, Cameron M, D'Abronzo, Leandro S, Lou, Wei, Chen, Hongwu, Dall'Era, Marc, Ghosh, Paramita M, Evans, Christopher P, Gao, Allen C
Publicado 2019

ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling

por Liu, Chengfei, Armstrong, Cameron M., Ning, Shu, Yang, Joy C., Lou, Wei, Lombard, Alan P., Zhao, Jinge, Wu, Chun-Yi, Yu, Aiming, Evans, Christopher P., Tepper, Clifford G., Li, Pui-kai, Gao, Allen C.
Publicado 2021

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer

por Liu, Chengfei, Lou, Wei, Yang, Joy C., Liu, Liangren, Armstrong, Cameron M., Lombard, Alan P., Zhao, Ruining, Noel, Onika D. V., Tepper, Clifford G., Chen, Hong-Wu, Dall’Era, Marc, Evans, Christopher P., Gao, Allen C.
Publicado 2018

XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies

por Baek, Han Bit, Lombard, Alan P., Libertini, Stephen J., Fernandez-Rubio, Aleida, Vinall, Ruth, Gandour-Edwards, Regina, Nakagawa, Rachel, Vidallo, Kathleen, Nishida, Kristine, Siddiqui, Salma, Wettersten, Hiromi, Landesman, Yosef, Weiss, Robert H., Ghosh, Paramita M., Mudryj, Maria
Publicado 2018

Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes

por Ning, Shu, Zhao, Jinge, Lombard, Alan P., D’Abronzo, Leandro S., Leslie, Amy R., Sharifi, Masuda, Lou, Wei, Liu, Chengfei, Yang, Joy C., Evans, Christopher P., Corey, Eva, Chen, Hong-Wu, Yu, Aiming, Ghosh, Paramita M., Gao, Allen C.
Publicado 2022